Literature DB >> 2646222

6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.

D H Present1.   

Abstract

The role of immunosuppressives in the treatment of Crohn's disease and ulcerative colitis will be reviewed. This will include a comprehensive presentation of the uncontrolled and controlled studies in both diseases. The author's personal experiences with more than 400 patients will be summarized, including efficacy and short- and long-term toxicity. A review of the literature regarding the risk of superinfections and neoplasia will be presented. Finally, specific indications for the use of 6-MP/azathioprine will be listed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646222

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  14 in total

Review 1.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

2.  Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis.

Authors:  L Braslow
Journal:  Ann Surg       Date:  1991-04       Impact factor: 12.969

3.  Toll-like receptor-7 ligand Imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis.

Authors:  Satheesh K Sainathan; Kumar S Bishnupuri; Konrad Aden; Qizhi Luo; Courtney W Houchen; Shrikant Anant; Brian K Dieckgraefe
Journal:  Inflamm Bowel Dis       Date:  2011-09-26       Impact factor: 5.325

Review 4.  Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.

Authors:  E G Quetglas; A Armuzzi; S Wigge; G Fiorino; L Barnscheid; M Froelich; Silvio Danese
Journal:  Eur J Clin Pharmacol       Date:  2015-05-27       Impact factor: 2.953

5.  Azathioprine reduces extravasation and neutrophil trafficking in immune complex-mediated inflammation in the rat colon.

Authors:  S N Murthy; T Anania; H R Clearfield
Journal:  Agents Actions       Date:  1991-09

Review 6.  Inflammatory bowel disease in the elderly. Practical treatment guidelines.

Authors:  G A Akerkar; M A Peppercorn
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

Review 7.  Monitoring thiopurine metabolites in inflammatory bowel disease.

Authors:  Yago González-Lama; Javier P Gisbert
Journal:  Frontline Gastroenterol       Date:  2016-04-07

8.  Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin.

Authors:  S N Murthy; H S Cooper; H Shim; R S Shah; S A Ibrahim; D J Sedergran
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

9.  Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity.

Authors:  C N Bernstein; L Artinian; P A Anton; F Shanahan
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

Review 10.  New developments in the pharmacotherapy of inflammatory bowel disease.

Authors:  J W Harting
Journal:  Pharm Weekbl Sci       Date:  1992-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.